Dynavax Technologies Stock Buy Hold or Sell Recommendation
| DVAX Stock | USD 11.84 0.04 0.34% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Dynavax Technologies is 'Hold'. Macroaxis provides Dynavax Technologies buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DVAX positions. The advice algorithm takes into account all of Dynavax Technologies' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Dynavax Technologies' buy or sell advice are summarized below:
Real Value 15.06 | Target Price 24.5 | Hype Value 11.73 | Market Value 11.84 | Naive Value 11.35 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Dynavax Technologies given historical horizon and risk tolerance towards Dynavax Technologies. When Macroaxis issues a 'buy' or 'sell' recommendation for Dynavax Technologies, the advice is generated through an automated system that utilizes algorithms and statistical models.
Dynavax |
Execute Dynavax Technologies Buy or Sell Advice
The Dynavax recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dynavax Technologies. Macroaxis does not own or have any residual interests in Dynavax Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dynavax Technologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Dynavax Technologies Trading Alerts and Improvement Suggestions
| Dynavax Technologies generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 232.28 M. Net Loss for the year was (6.39 M) with profit before overhead, payroll, taxes, and interest of 448.22 M. | |
| Dynavax Technologies has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 CAGR of 3.9 |
Dynavax Technologies Returns Distribution Density
The distribution of Dynavax Technologies' historical returns is an attempt to chart the uncertainty of Dynavax Technologies' future price movements. The chart of the probability distribution of Dynavax Technologies daily returns describes the distribution of returns around its average expected value. We use Dynavax Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dynavax Technologies returns is essential to provide solid investment advice for Dynavax Technologies.
| Mean Return | -0.25 | Value At Risk | -2.9 | Potential Upside | 2.50 | Standard Deviation | 1.58 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dynavax Technologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dynavax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Dynavax Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dynavax Technologies backward and forwards among themselves. Dynavax Technologies' institutional investor refers to the entity that pools money to purchase Dynavax Technologies' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.5 M | Blair William & Co | 2023-12-31 | 2.4 M | Renaissance Technologies Corp | 2023-12-31 | 1.9 M | Rock Springs Capital Management Lp | 2023-12-31 | 1.7 M | Driehaus Capital Management Llc | 2023-12-31 | 1.6 M | Kynam Capital Management, Lp | 2023-12-31 | 1.5 M | Northern Trust Corp | 2023-12-31 | 1.4 M | Fisher Asset Management, Llc | 2023-12-31 | 1.4 M | Woodline Partners Lp | 2023-12-31 | 1.3 M | Blackrock Inc | 2023-12-31 | 23.4 M | Federated Hermes Inc | 2023-12-31 | 11.4 M |
Dynavax Technologies Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 29.4M | 11.1M | 9.5M | 7.1M | 4.1M | 5.4M | |
| End Period Cash Flow | 40.1M | 32.3M | 436.4M | 202.2M | 150.6M | 158.1M | |
| Change In Cash | (9.9M) | (7.8M) | 404.1M | (234.2M) | (51.7M) | (49.1M) | |
| Free Cash Flow | (150.7M) | (103.3M) | 326.1M | 55.6M | 96.5M | 101.3M | |
| Depreciation | 21.5M | 9.3M | 7.0M | 6.7M | 7.3M | 4.9M | |
| Other Non Cash Items | 12.0M | 3.7M | 1.6M | (33.4M) | 1.1M | 770K | |
| Net Income | (152.6M) | (75.2M) | 76.7M | 293.2M | (6.4M) | (6.7M) | |
| Change To Inventory | (22.3M) | (22.4M) | (234K) | (32.4M) | 3.9M | 4.1M | |
| Investments | (13.4M) | (22.3M) | 22.7M | (309.9M) | (166.7M) | (158.3M) | |
| Change Receivables | (5.2M) | (13.8M) | (109.2M) | (15.7M) | (14.1M) | (14.8M) | |
| Change To Netincome | 44.9M | 6.1M | 79.6M | 65.5M | 75.3M | 79.1M |
Dynavax Technologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dynavax Technologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dynavax Technologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dynavax stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.31 | |
β | Beta against NYSE Composite | 0.69 | |
σ | Overall volatility | 1.59 | |
Ir | Information ratio | -0.21 |
Dynavax Technologies Volatility Alert
Dynavax Technologies exhibits very low volatility with skewness of 0.09 and kurtosis of 0.48. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dynavax Technologies' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dynavax Technologies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dynavax Technologies Fundamentals Vs Peers
Comparing Dynavax Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dynavax Technologies' direct or indirect competition across all of the common fundamentals between Dynavax Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dynavax Technologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dynavax Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dynavax Technologies to competition |
| Fundamentals | Dynavax Technologies | Peer Average |
| Return On Equity | -0.0106 | -0.31 |
| Return On Asset | -0.0192 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | (0.12) % | (5.51) % |
| Current Valuation | 1.06 B | 16.62 B |
| Shares Outstanding | 130.86 M | 571.82 M |
| Shares Owned By Insiders | 0.31 % | 10.09 % |
| Shares Owned By Institutions | 97.99 % | 39.21 % |
| Number Of Shares Shorted | 17.97 M | 4.71 M |
| Price To Earning | 6.95 X | 28.72 X |
| Price To Book | 2.49 X | 9.51 X |
| Price To Sales | 6.67 X | 11.42 X |
| Revenue | 232.28 M | 9.43 B |
| Gross Profit | 448.22 M | 27.38 B |
| EBITDA | 20.98 M | 3.9 B |
| Net Income | (6.39 M) | 570.98 M |
| Cash And Equivalents | 518.17 M | 2.7 B |
| Cash Per Share | 4.10 X | 5.01 X |
| Total Debt | 256.91 M | 5.32 B |
| Debt To Equity | 0.61 % | 48.70 % |
| Current Ratio | 2.77 X | 2.16 X |
| Book Value Per Share | 4.80 X | 1.93 K |
| Cash Flow From Operations | 100.56 M | 971.22 M |
| Short Ratio | 9.51 X | 4.00 X |
| Earnings Per Share | (0.05) X | 3.12 X |
| Target Price | 25.75 | |
| Number Of Employees | 408 | 18.84 K |
| Beta | 1.28 | -0.15 |
| Market Capitalization | 1.54 B | 19.03 B |
| Total Asset | 997.1 M | 29.47 B |
| Retained Earnings | (930.58 M) | 9.33 B |
| Working Capital | 796.92 M | 1.48 B |
| Current Asset | 199.95 M | 9.34 B |
Note: Disposition of 88000 shares by John Slebir of Dynavax Technologies at 11.12 subject to Rule 16b-3 [view details]
Dynavax Technologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dynavax . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 62198.63 | |||
| Daily Balance Of Power | 0.1379 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 11.87 | |||
| Day Typical Price | 11.86 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | 0.04 |
About Dynavax Technologies Buy or Sell Advice
When is the right time to buy or sell Dynavax Technologies? Buying financial instruments such as Dynavax Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Total Liabilities | 816.9M | 404.8M | 375.0M | 393.8M | Other Stockholder Equity | 1.4B | 1.5B | 1.6B | 1.6B |
Use Investing Ideas to Build Portfolios
In addition to having Dynavax Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Dynavax Technologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.